Condition
Pigmentation Disorder
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (2)
Early P 1 (1)
P 2 (3)
Trial Status
Completed4
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04971200Early Phase 1Completed
Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo
NCT06122090Phase 2Recruiting
Treatment of Hypopigmented Scars With Bimatoprost
NCT05913102Not ApplicableUnknown
A Prospective, Split-face, Randomized Study of the Poly-D, L Lactic Acid (PDLLA) for Photoaged Skin
NCT05710068Not ApplicableCompleted
Effects of RF Microneedle on Photoaging Skin
NCT01085279Phase 2CompletedPrimary
Fractional Laser as Treatment Option for Various Pigment Disorders (Fractional-3)
NCT01083498Phase 2CompletedPrimary
Fractional Laser as Treatment Option for Various Pigment Disorders
Showing all 6 trials